Andere Sprachen SeaStar Medical Holding Corporation

Aktien

A3DSWS

US81256L1044

ICU

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 31.05.2024			% 5 Tage	% 1. Jan.
0,3714 ^USD	+1,42 %		-0,51 %	-16,11 %

14.05.	SeaStar Medical Holding Corporation meldet die Ergebnisse für das erste Quartal bis zum 31. März 2024	CI
16.04.	SeaStar Medical Holding Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SeaStar Medical Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Seastar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	12.03.
SeaStar Medical Receives FDA Approval for Pediatric Kidney Treatment Device	22.02.
FDA Grants Humanitarian Device Exemption Approval to Seastar Medical?S Selective Cytopheretic Device for Pediatric Acute Kidney Injury	22.02.
SeaStar Medical Gets Canadian Patent Covering Technology for Cell-Directed Therapy	01.02.
Correction: SeaStar Medical Holding Prices $9 Million Registered Direct Stock Offering	26.01.
SeaStar Medical Holding Prices $9 Million Registered Direct Stock Offering	26.01.
SeaStar Medical Names David Green as Chief Financial Officer; Shares Rise After Hours	11.01.
SeaStar Enrolls Patients in Selective Cytopheretic Device Trial in Adults With Acute Kidney Injury	28.12.
SeaStar Medical Holding Corporation Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury	28.12.
SeaStar Medical Forms Scientific Advisory Board of Pediatric and Adult Clinical Experts	13.12.
SeaStar Medical Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
SeaStar Medical Asked to Revise Product Label, Modify Study Plan for Medical Device Approval	30.10.23
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	30.10.23
U.S. Food and Drug Administration Issues Approvable Letter for SeaStar Medical Holding Corporation's Selective Cytopheretic Device for Pediatric Patients	30.10.23
Sector Update: Health Care Stocks Slip in Late Afternoon	27.10.23
Sector Update: Health Care Stocks Retreating in Afternoon Trading	27.10.23
Sector Update: Health Care	27.10.23
SeaStar Medical Holding Shares Soar After Withdrawal of Registration Statement	27.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SeaStar Medical Holding Corporation

Aktien

A3DSWS

US81256L1044

ICU

Andere Sprachen

Filter